Loading…
Cholesterol vehicle in experimental atherosclerosis. 21. native and randomized lard and tallow
Tallow and lard are used as representative animal fats in experimental diets. We have compared their respective atherogenic properties by feeding each fat (14%) as part of a semi-purified diet containing 0.5% cholesterol. The lard containing diet was significantly ( P < 0.001) more atherogenic th...
Saved in:
Published in: | The Journal of nutritional biochemistry 1998-10, Vol.9 (10), p.582-585 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Tallow and lard are used as representative animal fats in experimental diets. We have compared their respective atherogenic properties by feeding each fat (14%) as part of a semi-purified diet containing 0.5% cholesterol. The lard containing diet was significantly (
P < 0.001) more atherogenic than the diet containing tallow. Lard and tallow both contain approximately 24% palmitic acid (16:0) but the palmitic acid is distributed differently in their component triglyceride molecules. Over 90% of 16:0 of lard is at the SN
2 position, whereas only approximately 15% of the 16:0 of tallow is in that position. The fats were randomized so that every component fatty acid was present at each triglyceride carbon to approximately one third of its total concentration. Randomized tallow and lard had 8.5% and 7.6% of their component 16:0 at the SN
2 position, respectively. The atherogenicity of diets containing either randomized lard or tallow was virtually the same and significantly lower than the atherogenicity of the diet containing native lard. This study confirms earlier studies from our laboratory that suggest that the level of 16:0 at the SN
2 position of a triglyceride influences its atherogenicity. |
---|---|
ISSN: | 0955-2863 1873-4847 |
DOI: | 10.1016/S0955-2863(98)00053-9 |